Cite
MLA Citation
Eric Van Cutsem et al.. “Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study.” Oncologist, vol. 24, 2019, pp. 185–192. http://access.bl.uk/ark:/81055/vdc_100077484632.0x000035